bioRxivBiochemistryPreprint
Finely tuned DDA-PASEF-based immunopeptidomics workflow enhances HLA class I coverage
Jeewan Babu RijaliD, Aurélie HirschleriD, Arthur DeclercqiD, Margot Sommer, Charline KelleriD, Arnaud JungiD, Alexandre BureliD, Luc-Matthieu ForneckeriD, Delphine RollandiD, Ralf GabrielsiD, Lennart MartensiD, Christine CarapitoiD
Abstract
Mass spectrometry-based immunopeptidomics is essential for the direct identification of HLA-presented peptides, but its application to low-input and clinical samples remains challenging. In this study, we present an optimized DDA-PASEF-based workflow to improve HLA class I peptide coverage. First, we optimized a magnetic bead-based sample preparation protocol to support analysis from reduced starting material and increase compatibility with automation. We then evaluated LC gradient length and column dimensions to define complementary configurations for high-throughput and high-coverage analysis. For MS acquisition, we fine-tuned key parameters, including ion accumulation time, number of PASEF scans, ion mobility range, and polygon filtering, to improve sensitivity while maintaining a suitable cycle time and limiting pre-CID truncations. The customized polygon filter improved the detection of singly charged HLA class I peptides, thereby broadening the identified immunopeptide repertoire. Finally, TIMS2Rescore was integrated to improve confidence in peptide identification. Overall, this optimized workflow improves HLA class I immunopeptide coverage across different sample types, even from low injected sample amounts, supporting its future applicability to clinically relevant samples.
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- A platform for high-throughput and ultrasensitive immunopeptidomics
Adillah Gul, Laura Van Moortel, … Francis Impens·Molecular & Cellular ProteomicsPeer-reviewed·May 18, 2026
- Sensitive, high-throughput HLA-I and HLA-II immunopeptidomics using parallel accumulation-serial fragmentation mass spectrometry
K. Phulphagar, C. Ctortecka, … S. A. Carr·bioRxiv·Mar 10, 2023
- diaPASEF analysis for HLA-I peptides enables quantification of common cancer neoantigens
Denys Oliinyk, Hem R. Gurung, … Susan Klaeger·Molecular & Cellular ProteomicsPeer-reviewed·Mar 3, 2025
- Optimized liquid and gas phase fractionation increase HLA-peptidome coverage for primary cell and tissue samples
S. Klaeger, A. Apffel, … S. A. Carr·bioRxiv·May 25, 2021
- Data-independent immunopeptidomics discovery of low-abundant bacterial epitopes
Patrick Willems, An Staes, … Francis Impens·Journal of Proteome ResearchPeer-reviewed·Oct 30, 2025
- Validation of a high-performance liquid chromatography-tandem mass spectrometry immunopeptidomics assay for the identification of HLA class I ligands suitable for pharmaceutical therapies
M. Ghosh, M. Gauger, … S. Stevanovic·bioRxiv·Oct 29, 2019